Application and Research Progress of Crystal Forms of Dihydropyridine Antihypertensive Drugs
10.3870/j.issn.1004-0781.2019.02.013
- VernacularTitle:二氢吡啶类抗高血压药物的晶型应用与研究进展
- Author:
Tianyi YUAN
1
;
Di CHEN
;
Li ZHANG
;
Yang LYU
;
Lianhua FANG
;
Guanhua DU
Author Information
1. 中国医学科学院北京协和医学院药物研究所药物靶点研究与新药筛选北京市重点实验室
- Keywords:
Dihydropyridine;
Calcium channel blockers;
Crystalline drug;
Antihypertensive drugs
- From:
Herald of Medicine
2019;38(2):203-208
- CountryChina
- Language:Chinese
-
Abstract:
Dihydropyridine (DHP) calcium channel blockers drugs (dipine in drug names) are currently used in the treatment of hypertension clinically. In recent years, with the emergence of generic drugs, it has been found that the drug efficacy is quite different from that of the original drug, and the reason is closely related to the difference in the crystal forms of the oral preparations. This paper reviews the polymorphic phenomenon of some DHP calcium channel blockers in the domestic market, introduces the clinical application and research progress of the DHP drugs, analyzes the differences between different crystal forms of the same drugs. This work may provide references and ideas for the research and development of generic drugs or new crystalline drug of DHP drugs.
